Treatment device for rheumatism patients

Abstract

This invention provides a treatment device for patients with rheumatism, relating to the field of treatment equipment technology, including: an installation mechanism; the installation mechanism includes an inner groove and a cam, the inner groove being located at the inner end of the main body of the installation mechanism. In use, the roller contacts the patient's waist, and the installation tube drives the roller to move. The roller is driven by friction with the patient's back. When the drug outlet on the roller connects with the docking groove, the drug can be sprayed out through the drug outlet and the docking groove. By arranging the drug outlets in a row, the drug can only move forward when sprayed, effectively preventing the drug from spreading outwards and wasting it. This solves the problem that rheumatism treatment devices simply spray the drug onto the patient's skin surface without massaging the skin to promote drug absorption, thus failing to achieve the expected therapeutic effect.

Description

Technical Field

[0001] This invention relates to the field of treatment equipment technology, and in particular to a treatment device for patients with rheumatism. Background Technology

[0002] Rheumatic diseases are a very common clinical syndrome characterized by joint pain and aversion to wind and cold. Treatment of rheumatic diseases requires a combination of drug therapy and physical therapy. Physical therapy typically involves heating and atomizing liquid medication, then spraying the atomized medication onto the patient's skin using a treatment device to achieve a therapeutic effect. However, current traditional rheumatic disease treatment devices have imperfect spraying structures. During use, the atomized medication easily disperses, preventing complete application to the patient's skin and resulting in medication waste. Furthermore, existing devices simply spray medication onto the skin without massaging the skin to promote absorption, thus failing to achieve the desired therapeutic effect. Summary of the Invention

[0003] In view of this, the present invention provides a treatment device for patients with rheumatism, which has a movable part that can massage the skin while spraying medication, thereby helping to improve the absorption rate of the medication.

[0004] This invention provides a treatment device for patients with rheumatism, specifically comprising:

[0005] The installation mechanism includes an inner groove and a cam. The inner groove is located at the inner end of the main body of the installation mechanism, and its bottom is connected to a rectangular through groove on the main body through a circular through hole. The cam is rotatably installed in the inner groove, and is connected to a motor on the main body through a connecting shaft. The installation mechanism has a movable part, and the mounting frame of the movable part is slidably installed in the rectangular through groove inside the main body. The side groove of the mounting frame is connected to the connecting groove of the main body. The top of the connecting rod in the movable part passes through the main body and is inserted into the inner groove. An elastic element is provided between the top of the connecting rod and the inner groove, and the top of the connecting rod contacts the cam. The movable part has three sets of drug-applying components, and the connecting pipe of the drug-applying components is located inside the mounting frame. Both ends of the connecting pipe are connected to the docking groove of the mounting frame. The installation mechanism has a limiting component, and the fixing parts of the limiting component are symmetrically located at both ends of the front side of the main body. The fixing parts are located on both sides of the rectangular through groove inside the main body. The installation mechanism has a fixing part, and the prefabricated part of the fixing part is located at the lower end of the main body. The prefabricated part is hinged to the main body.

[0006] Optionally, the installation mechanism further includes: a main body, a motor is provided at the upper front end of the main body, and a rectangular through hole is provided at the middle of the lower end of the main body; a connecting groove, which is symmetrically provided at both ends of the inner side of the main body, and the connecting groove penetrates the front side of the main body, and the connecting groove is connected to the rectangular through groove in the main body through five sets of circular through holes.

[0007] Optionally, the movable part includes: a mounting frame, which is a rectangular ring structure; a connecting rod, which is located at the upper end of the mounting frame, and the top of the connecting rod is a spherical structure, and a rectangular limiting plate is provided at the upper end of the connecting rod.

[0008] Optionally, the movable part further includes: a docking groove, which has six sets and is symmetrically opened on both sides inside the mounting frame; and a side groove, which is symmetrically opened on both sides of the mounting frame and is connected to the docking groove.

[0009] Optionally, the drug delivery assembly includes: a connecting tube, which has three sets and is cylindrical; and a drug outlet, which has five sets and is located at the front end of the connecting tube.

[0010] Optionally, the drug application assembly further includes: a roller, which is sleeved on the outer end of the connecting pipe; and drug outlets, which are arranged in a row on the outside of the roller and penetrate through the roller, with the five sets of drug outlets at the front middle position connected to the drug outlet.

[0011] Optionally, the limiting component includes: a fixing member, which has two sets of fixing members and two sets of rectangular protrusions symmetrically arranged on the front side of the fixing member; and a sliding groove, which has two sets of sliding grooves and is opened on the rectangular protrusions on the front side of the fixing member.

[0012] Optionally, the limiting component further includes: a movable member, which is slidably mounted on the fixed member and passes through the slide groove, and an elastic member is provided between the movable member and the fixed member; and a guide roller, which is provided in three sets and is rotatably mounted on the inner rear side of the movable member.

[0013] Optionally, the fixing part includes: a preform with a rectangular groove inside; and a guide groove symmetrically located at the inner end of the preform and connected to the rectangular groove inside the preform.

[0014] Optionally, the fixing part further includes: a top plate, which is slidably installed in a rectangular groove in the precast component, and rectangular protrusions on both sides of the outer side of the top plate are slidably installed in guide grooves; and a screw, which is rotatably installed at the bottom of the top plate, and the screw passes through the precast component and is threadedly connected to the precast component.

[0015] Beneficial effects

[0016] According to various embodiments of the present invention, the rheumatism treatment device, compared with the traditional treatment device, is provided with a mounting frame that drives the roller to move, which can massage the affected area while applying medicine to the patient, effectively improving the absorption rate of the medicine and avoiding the problem of the medicine remaining on the skin and not being fully absorbed. In addition, a medicine outlet is opened on the connecting tube, so that when applying medicine, the medicine can only flow out from the leakage hole on one side, which can effectively avoid the waste of medicine.

[0017] In this invention, a movable part is provided, and an inner groove is opened in the main body. A cam connected to a motor is rotated and installed in the inner groove. An installation frame is slidably set in a rectangular through groove in the main body, and the connecting rod at the top of the installation frame is inserted into the inner groove at the upper end of the main body. An elastic element is set between the connecting rod and the inner groove, and the top of the connecting rod contacts the cam. A connecting groove is opened on the main body, and the docking groove is connected to the connecting groove through a side groove. A roller with a connecting tube is installed inside the installation frame, and both ends of the connecting tube are connected to the docking groove. In use, the device is placed against the back of the patient and fixed by a limiting component. The drug nebulizer is connected to the outer end of the connecting groove, so that the nebulized drug is delivered to the connecting tube through the docking groove. At this time, the motor is started, and the motor drives the roller to move back and forth on the patient's waist through the installation frame. By connecting the drug outlet and the drug leakage outlet, the drug can leak out from the drug leakage outlet and be delivered to the patient's affected area. The roller rolls back and forth on the patient's affected area to promote the absorption of the drug by the skin.

[0018] In this invention, a medication application component is provided. Six sets of docking grooves are set in the mounting frame, and three sets of connecting pipes are fixedly installed inside the mounting frame, with both ends of the connecting pipes connected to the docking grooves. Five sets of circular medication outlets are opened on the front side of the connecting pipes. A roller is fitted onto the connecting pipe, and medication leakage outlets are evenly spaced on the roller. The five sets of medication leakage outlets in the middle of the front side are connected to the medication outlets. In use, the roller is brought into contact with the patient's waist, and the mounting pipe drives the roller to move. The roller is driven by friction with the patient's back. When the medication leakage outlets on the roller are connected to the docking grooves, the medication can be sprayed out through the leakage outlets and docking grooves. By setting the medication outlets in a row, the medication can only move forward when sprayed, effectively preventing the medication from spreading in all directions and thus avoiding medication waste. Attached Figure Description

[0019] To more clearly illustrate the technical solutions of the embodiments of the present invention, the accompanying drawings of the embodiments will be briefly described below.

[0020] The accompanying drawings described below are only related to some embodiments of the invention and are not intended to limit the invention.

[0021] In the attached diagram:

[0022] Figure 1 A three-dimensional structural schematic diagram according to an embodiment of the present invention is shown;

[0023] Figure 2 A schematic diagram of the rear view structure according to an embodiment of the present invention is shown;

[0024] Figure 3 An exploded structural diagram according to an embodiment of the present invention is shown;

[0025] Figure 4 A partial cross-sectional view of the structure according to an embodiment of the present invention is shown;

[0026] Figure 5 The invention is illustrated by an embodiment of the invention. Figure 4 A schematic diagram of the enlarged structure of part A is shown;

[0027] Figure 6 The invention is illustrated by an embodiment of the invention. Figure 4 A schematic diagram of the enlarged structure of section B is shown;

[0028] Figure 7 A schematic diagram of a partial connection structure according to an embodiment of the present invention is shown;

[0029] Figure 8 A three-dimensional structural diagram of the limiting component according to an embodiment of the present invention is shown;

[0030] Figure 9 A schematic diagram of the internal structure of the drug delivery component according to an embodiment of the present invention is shown.

[0031] List of reference numerals in the attached diagram:

[0032] 1. Installation mechanism;

[0033] 101. Main body; 1011. Connecting groove;

[0034] 102. Inner groove; 1021. Cam;

[0035] 2. Activities Department;

[0036] 201. Mounting frame; 2011. Connecting rod;

[0037] 202. Connecting groove; 203. Side groove;

[0038] 3. Drug application components;

[0039] 301, connecting pipe; 3011, drug outlet;

[0040] 302, roller; 3021, medicine leakage port;

[0041] 4. Limiting components;

[0042] 401, Fastener; 4011, Slide;

[0043] 402. Moving parts; 4021. Guide rollers;

[0044] 5. Fixing part;

[0045] 501, Precast component; 5011, Guide groove;

[0046] 502, top plate; 5021, screw. Detailed Implementation

[0047] To make the objectives, solutions, and advantages of the present invention clearer, the technical solutions of the embodiments of the present invention will be clearly and completely described below with reference to the accompanying drawings. Unless otherwise stated, the terms used herein have their ordinary meanings in the art. The same reference numerals in the drawings represent the same parts.

[0048] Example: Please refer to Figures 1 to 9 :

[0049] This invention proposes a treatment device for patients with rheumatism, comprising: a mounting mechanism 1; the mounting mechanism 1 includes an inner groove 102 and a cam 1021, the inner groove 102 being formed at the inner end of the main body 101 of the mounting mechanism 1, and the bottom of the inner groove 102 communicating with a rectangular through groove on the main body 101 through a circular through hole, the cam 1021 being rotatably mounted in the inner groove 102, and the cam 1021 being connected to a motor on the main body 101 through a connecting shaft; the mounting mechanism 1 is provided with a movable part 2, and the mounting frame 201 of the movable part 2 is slidably mounted in the rectangular through groove inside the main body 101, and the side groove 203 of the mounting frame 201 communicating with the connecting groove 1011 of the main body 101, the top of the connecting rod 2011 in the movable part 2 penetrating through the main body 101. The connecting rod 2011 is inserted into the inner groove 102, and an elastic element is provided between the top of the connecting rod 2011 and the inner groove 102, and the top of the connecting rod 2011 contacts the cam 1021; the movable part 2 is provided with three sets of drug-feeding components 3, and the connecting pipe 301 of the drug-feeding components 3 is located inside the mounting frame 201, and both ends of the connecting pipe 301 are connected to the docking groove 202 of the mounting frame 201; the mounting mechanism 1 is provided with a limiting component 4, and the fixing parts 401 of the limiting component 4 are symmetrically arranged at both ends of the front side of the main body 101, and the fixing parts 401 are located on both sides of the rectangular through groove inside the main body 101; the mounting mechanism 1 is provided with a fixing part 5, and the prefabricated part 501 of the fixing part 5 is located at the lower end of the main body 101, and the prefabricated part 501 is hinged to the main body 101.

[0050] Furthermore, according to embodiments of the present invention, such as Figure 4As shown, the installation mechanism 1 also includes: a main body 101, a motor is provided at the upper front end of the main body 101, and a rectangular through hole is provided at the middle of the lower end of the main body 101; a connecting groove 1011, which is symmetrically provided at both ends of the inner side of the main body 101, and the connecting groove 1011 penetrates the front side of the main body 101, and the connecting groove 1011 is connected to the rectangular through groove in the main body 101 through five sets of circular through holes; a plate-shaped main body 101 is provided, and a cam 1021 can be rotatably installed in the main body 101; and the connecting groove 1011 is provided, so that the atomized medicine can be transported to the drug delivery component 3 through the connecting groove 1011.

[0051] Furthermore, according to embodiments of the present invention, such as Figure 7 As shown, the movable part 2 includes: a mounting frame 201, which is a rectangular ring structure; a connecting rod 2011, which is located at the upper end of the mounting frame 201, and the top of the connecting rod 2011 is a spherical structure, and a rectangular limiting plate is provided at the upper end of the connecting rod 2011; the mounting frame 201 is provided so that the medicine application component 3 can be installed into the mounting frame 201, and the circular connecting rod 2011 can be pushed by the cam 1021 to move the mounting frame 201. The mounting frame 201 has six sets of docking grooves 202, which are symmetrically arranged on both sides of the mounting frame 201. The mounting frame 201 also has side grooves 203, which are symmetrically arranged on both sides of the mounting frame 201 and are connected to the docking grooves 202. The circular docking grooves 202 can be used to connect the connecting pipe 301 to the side grooves 203, while the rectangular side grooves 203 can be used to connect the connecting pipe 301 to the connecting groove 1011.

[0052] Furthermore, according to embodiments of the present invention, such as Figure 9 As shown, the drug delivery assembly 3 includes: a connecting pipe 301, of which three sets are provided, and the connecting pipe 301 has a cylindrical structure; and a drug outlet 3011, of which five sets are provided, and the drug outlets 3011 are located at the front end of the connecting pipe 301. The connecting pipe 301 allows the roller 302 to be mounted onto the mounting frame 201 via the connecting pipe 301. The drug outlets 3011 allow the atomized drug within the connecting pipe 301 to be delivered into the roller 302 via the drug outlets 3011. Roller 302 is sleeved on the outer end of connecting tube 301; medicine leakage port 3021 is arranged in a row on the outside of roller 302 and penetrates roller 302. The five sets of medicine leakage ports 3021 in the middle of the front side are connected to medicine outlet 3011. Roller 302 is set so that the patient can be massaged by rotating roller 302. When medicine leakage port 3021 is connected to medicine outlet 3011, the medicine in connecting tube 301 can be sprayed onto the patient's back.

[0053] Furthermore, according to embodiments of the present invention, such as Figure 8 As shown, the limiting component 4 includes: a fixing member 401, of which two sets are provided, and two sets of rectangular protrusions are symmetrically provided on the front side of the fixing member 401; and a sliding groove 4011, of which two sets are provided, and the sliding groove 4011 is formed on the rectangular protrusions on the front side of the fixing member 401. The fixing member 401 is provided to allow the movable member 402 to be installed onto the main body 101, and the circular sliding groove 4011 is provided to allow the movable member 402 to pass through the sliding groove 401. 1. A movable part 402 is slidably installed on the fixed part 401 and passes through the slide groove 4011. An elastic element is provided between the movable part 402 and the fixed part 401. 2. A guide roller 4021 is provided. There are three sets of guide rollers 4021. The guide rollers 4021 are rotatably installed on the inner rear side of the movable part 402. The movable part 402 is configured to fix the main body 101 to the back of the patient by tightening the movable part 402.

[0054] Furthermore, according to embodiments of the present invention, such as Figure 2-3 As shown, the fixing part 5 includes: a prefabricated part 501, the prefabricated part 501 having a rectangular groove inside; a guide groove 5011, the guide groove 5011 being symmetrically opened at the inner end of the prefabricated part 501, and the guide groove 5011 communicating with the rectangular groove inside the prefabricated part 501; a C-shaped prefabricated part 501 is provided, which is snapped onto the table and chair, so that the main body 101 can be fixed to the table body through the prefabricated part 501; a rectangular guide groove 5011 is provided, and the rectangular protrusion at the outer end of the top plate 502 is snapped into the guide groove 5011, which can play a guiding role when the top plate 502 moves. 502, the top plate 502 is slidably installed in the rectangular groove in the precast part 501, and the rectangular protrusions on both sides of the outer side of the top plate 502 are slidably installed in the guide groove 5011; the screw 5021 is rotatably installed at the bottom of the top plate 502, and the screw 5021 passes through the precast part 501, and the screw 5021 is threadedly connected to the precast part 501. The rectangular top plate 502 is set, and the screw 5021 is rotatably installed at the bottom of the top plate 502. The top plate 502 can be moved upward by the active screw 5021 and clamp the table and chair, so that the precast part 501 is fixed on the table and chair.

[0055] The specific usage and function of this embodiment are as follows:

[0056] In this invention, such as Figure 1-9As shown, the prefabricated component 501 is snapped onto the table and chair, and the top plate 502 clamps the table and chair by tightening the screw 5021, thus fixing the prefabricated component 501 onto the table and chair. The main body 101 is installed onto the prefabricated component 501 via the connecting shaft. The fixing component 401 is installed onto the rear end of the main body 101, and the moving component 402 is installed on the fixing component 401 via the elastic component. Pulling the moving component 402, the main body 101 is placed behind the patient. Releasing the moving component 402 allows the elastic component to push the moving component 402 to clamp the patient's waist. An inner groove 102 is opened inside the main body 101, and a cam 1021 connected to a motor is rotated and installed into the inner groove 102. The mounting frame 201 is slidably installed into the rectangular through groove inside the main body 101, and the connecting rod 2011 at the top of the mounting frame 201 is inserted. The connecting rod 2011 is brought into contact with the cam 1021 in the main inner groove 102. A connecting groove 1011 is opened on the main body 101, and the docking groove 202 is connected to the connecting groove 1011 through the side groove 203. The roller 302 with the connecting tube 301 is installed inside the mounting frame 201, and both ends of the connecting tube 301 are connected to the docking groove 202. The main body 101 is placed against the back of the patient. The drug nebulizer is connected to the outer end of the connecting groove 1011, so that the nebulized drug is delivered into the connecting tube 301 through the docking groove 202. The motor is started, and the motor drives the roller 302 to move back and forth on the patient's waist through the mounting frame 201. By connecting the drug outlet 3011 with the drug leakage outlet 3021, the drug can leak out from the drug leakage outlet 3021 and be delivered to the patient's affected area.

[0057] Finally, it should be noted that when describing the position of each component and the mating relationship between them, the present invention usually uses one or a pair of components as examples. However, those skilled in the art should understand that such positions, mating relationships, etc., are also applicable to other components or other pairs of components.

[0058] The above description is merely an exemplary embodiment of the present invention and is not intended to limit the scope of protection of the present invention, which is determined by the appended claims.

Claims

1. A treatment device for patients with rheumatism, characterized in that, include: Mounting mechanism (1); The mounting mechanism (1) includes an inner groove (102) and a cam (1021). The inner groove (102) is opened at the inner end of the main body (101) of the mounting mechanism (1), and the bottom of the inner groove (102) is connected to the rectangular through groove on the main body (101) through a circular through hole. The cam (1021) is rotatably mounted in the inner groove (102), and the cam (1021) is connected to the motor on the main body (101) through a connecting shaft. The mounting mechanism (1) is provided with a movable part (2), and the mounting frame (201) of the movable part (2) is slidably mounted in the rectangular through groove in the main body (101). The side groove (203) of the mounting frame (201) is connected to the connecting groove (1011) of the main body (101). The top of the connecting rod (2011) in the movable part (2) passes through the main body (101) and is inserted into the inner groove (102). In the middle, an elastic element is provided between the top of the connecting rod (2011) and the inner groove (102), and the top of the connecting rod (2011) is in contact with the cam (1021); the movable part (2) is provided with three sets of drug application components (3), and the connecting pipe (301) of the drug application component (3) is located inside the mounting frame (201), and the two ends of the connecting pipe (301) are connected to the docking groove (202) of the mounting frame (201); the mounting mechanism (1) is provided with a limiting component (4), and the fixing parts (401) of the limiting component (4) are symmetrically arranged at both ends of the front side of the main body (101), and the fixing parts (401) are located on both sides of the rectangular through groove inside the main body (101); the mounting mechanism (1) is provided with a fixing part (5), and the prefabricated part (501) of the fixing part (5) is located at the lower end of the main body (101), and the prefabricated part (501) is hinged to the main body (101); The installation mechanism (1) further includes: a main body (101), a motor is provided at the upper front end of the main body (101), and a rectangular through hole is provided at the middle of the lower end of the main body (101); a connecting groove (1011), which is symmetrically opened at both ends of the inner side of the main body (101), and the connecting groove (1011) penetrates the front side of the main body (101), and the connecting groove (1011) is connected to the rectangular through groove in the main body (101) through five sets of circular through holes; The drug delivery assembly (3) includes: a connecting tube (301), which has three sets and is cylindrical; and a drug outlet (3011), which has five sets and is located at the front end of the connecting tube (301). The drug application assembly (3) further includes: a roller (302), which is sleeved on the outer end of the connecting pipe (301); and a drug leakage port (3021), which is equidistantly opened on the outside of the roller (302) and penetrates the roller (302), and the five sets of drug leakage ports (3021) at the middle position on the front side are connected to the drug outlet (3011); The limiting component (4) includes: a fixing member (401), which has two sets, and two sets of rectangular protrusions are symmetrically provided on the front side of the fixing member (401); and a sliding groove (4011), which has two sets, and the sliding groove (4011) is opened on the rectangular protrusions on the front side of the fixing member (401).

2. The treatment device for rheumatism patients as described in claim 1, characterized in that: The active part (2) includes: a mounting frame (201), which is a rectangular ring structure; a connecting rod (2011), which is located at the upper end of the mounting frame (201), and the top of the connecting rod (2011) is a spherical structure, and a rectangular limiting plate is provided at the upper end of the connecting rod (2011).

3. The treatment device for rheumatism patients as described in claim 2, characterized in that: The active part (2) further includes: a docking groove (202), which has six sets and is symmetrically opened on both sides inside the mounting frame (201); and a side groove (203), which is symmetrically opened on both sides of the mounting frame (201) and is connected to the docking groove (202).

4. The treatment device for rheumatism patients as described in claim 1, characterized in that: The limiting component (4) further includes: a movable part (402), which is slidably mounted on the fixed part (401) and passes through the slide groove (4011), and an elastic part is provided between the movable part (402) and the fixed part (401); a guide roller (4021), which is provided in three sets and is rotatably mounted on the inner rear side of the movable part (402).

5. The treatment device for rheumatism patients as described in claim 1, characterized in that: The fixing part (5) includes: a preform (501), which has a rectangular groove inside; and a guide groove (5011), which is symmetrically opened at the inner end of the preform (501) and is connected to the rectangular groove inside the preform (501).

6. The treatment device for rheumatism patients as described in claim 5, characterized in that: The fixing part (5) further includes: a top plate (502), which is slidably installed in a rectangular groove in the preform (501), and rectangular protrusions on both sides of the outer side of the top plate (502) are slidably installed in the guide groove (5011); a screw (5021), which is rotatably installed at the bottom of the top plate (502), and the screw (5021) passes through the preform (501), and the screw (5021) is threadedly connected to the preform (501).

Images